ZA200604971B - 3-Cyano-quinoline derivatives with antiproliferative activity - Google Patents
3-Cyano-quinoline derivatives with antiproliferative activityInfo
- Publication number
- ZA200604971B ZA200604971B ZA200604971A ZA200604971A ZA200604971B ZA 200604971 B ZA200604971 B ZA 200604971B ZA 200604971 A ZA200604971 A ZA 200604971A ZA 200604971 A ZA200604971 A ZA 200604971A ZA 200604971 B ZA200604971 B ZA 200604971B
- Authority
- ZA
- South Africa
- Prior art keywords
- cyano
- antiproliferative activity
- quinoline derivatives
- quinoline
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP03/51059 | 2003-12-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200604971B true ZA200604971B (en) | 2009-05-27 |
Family
ID=34684508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200604971A ZA200604971B (en) | 2003-12-18 | 2006-06-15 | 3-Cyano-quinoline derivatives with antiproliferative activity |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US7655642B2 (de) |
| EP (1) | EP1696914B1 (de) |
| JP (1) | JP4892353B2 (de) |
| KR (1) | KR101158440B1 (de) |
| CN (1) | CN1893944B (de) |
| AR (1) | AR047060A1 (de) |
| AT (1) | ATE446750T1 (de) |
| AU (1) | AU2004298784B2 (de) |
| BR (1) | BRPI0417609B8 (de) |
| CA (1) | CA2549728C (de) |
| DE (1) | DE602004023876D1 (de) |
| EA (1) | EA200601176A1 (de) |
| ES (1) | ES2335216T3 (de) |
| HK (1) | HK1095742A1 (de) |
| IL (1) | IL176358A (de) |
| MX (1) | MXPA06007018A (de) |
| NO (1) | NO337622B1 (de) |
| NZ (1) | NZ547795A (de) |
| SG (1) | SG151288A1 (de) |
| TW (2) | TWI389890B (de) |
| UA (1) | UA83880C2 (de) |
| WO (1) | WO2005058318A1 (de) |
| ZA (1) | ZA200604971B (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA06007018A (es) * | 2003-12-18 | 2006-08-31 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-quinolino con actividad anti-proliferativa. |
| EP1697384B1 (de) * | 2003-12-18 | 2008-04-02 | Janssen Pharmaceutica N.V. | Pyrido- und pyrimidopyrimidinderivate als anti-proliferative mittel |
| NI200700147A (es) | 2004-12-08 | 2019-05-10 | Janssen Pharmaceutica Nv | Derivados de quinazolina inhibidores de cinasas dirigidos a multip |
| JO3088B1 (ar) * | 2004-12-08 | 2017-03-15 | Janssen Pharmaceutica Nv | مشتقات كوينازولين كبيرة الحلقات و استعمالها بصفتها موانع كينيز متعددة الاهداف |
| MY169441A (en) | 2004-12-08 | 2019-04-11 | Janssen Pharmaceutica Nv | 2,4, (4,6) pyrimidine derivatives |
| WO2007058627A1 (en) | 2005-11-16 | 2007-05-24 | S*Bio Pte Ltd | Oxygen linked pyrimidine derivatives |
| US10517876B2 (en) | 2005-11-16 | 2019-12-31 | Cti Biopharma Corp. | Oxygen linked pyrimidine derivatives |
| WO2008006884A2 (en) * | 2006-07-13 | 2008-01-17 | Janssen Pharmaceutica N.V. | Mtki quinazoline derivatives |
| WO2008087736A1 (ja) * | 2007-01-19 | 2008-07-24 | Ube Industries, Ltd. | アラルキルオキシ又はヘテロアラルキルオキシ基を有する芳香族アミンの製法 |
| ES2435454T3 (es) * | 2007-06-21 | 2013-12-19 | Janssen Pharmaceutica, N.V. | Indolin-2-onas y aza-indolin-2-onas |
| EP2185562B1 (de) | 2007-07-27 | 2015-12-02 | Janssen Pharmaceutica, N.V. | Zur behandlung proliferativer erkrankungen geeignete pyrrolopyrimidine |
| CN102127087B (zh) * | 2011-01-21 | 2012-07-04 | 江苏先声药物研究有限公司 | 喹唑啉衍生物 |
| MA39822A (fr) | 2014-04-03 | 2018-02-06 | Janssen Pharmaceutica Nv | Dérivés de pyrimidine bicycle |
| MA39823A (fr) | 2014-04-03 | 2018-01-09 | Janssen Pharmaceutica Nv | Dérivés de pyridine macrocyclique |
| BR112018006873A2 (pt) | 2015-10-05 | 2018-11-06 | The Trustees Of Columbia University In The City Of New York | ativadores do fluxo autofágico e fosfolipase d e depuração de agregados de proteína incluindo tau e tratamento de proteinopatias |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5028613A (en) | 1990-02-16 | 1991-07-02 | Repligen Corporation | Novel pyrroloquinoline alkaloids and methods of use |
| UA73073C2 (uk) | 1997-04-03 | 2005-06-15 | Уайт Холдінгз Корпорейшн | Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція |
| US6002008A (en) * | 1997-04-03 | 1999-12-14 | American Cyanamid Company | Substituted 3-cyano quinolines |
| DK1117659T3 (da) | 1998-09-29 | 2004-03-22 | Wyeth Corp | Substituerede 3-cyanoquinoliner som hæmmere af proteintyrosinkinaser |
| US6288082B1 (en) * | 1998-09-29 | 2001-09-11 | American Cyanamid Company | Substituted 3-cyanoquinolines |
| CN1642552B (zh) | 2002-03-30 | 2010-05-12 | 贝林格尔英格海姆法玛两合公司 | 作为酪氨酸激酶抑制剂的4-(n-苯氨基)-喹唑啉/喹啉 |
| JO2785B1 (en) * | 2003-05-27 | 2014-03-15 | شركة جانسين فارماسوتيكا ان. في | Quinazoline derivatives |
| MXPA06007018A (es) | 2003-12-18 | 2006-08-31 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-quinolino con actividad anti-proliferativa. |
-
2004
- 2004-12-15 MX MXPA06007018A patent/MXPA06007018A/es active IP Right Grant
- 2004-12-15 AU AU2004298784A patent/AU2004298784B2/en active Active
- 2004-12-15 KR KR1020067014235A patent/KR101158440B1/ko active IP Right Grant
- 2004-12-15 EP EP04804849A patent/EP1696914B1/de active Active
- 2004-12-15 AT AT04804849T patent/ATE446750T1/de not_active IP Right Cessation
- 2004-12-15 JP JP2006544439A patent/JP4892353B2/ja active Active
- 2004-12-15 ES ES04804849T patent/ES2335216T3/es active Active
- 2004-12-15 UA UAA200607006A patent/UA83880C2/ru unknown
- 2004-12-15 CA CA2549728A patent/CA2549728C/en active Active
- 2004-12-15 EA EA200601176A patent/EA200601176A1/ru unknown
- 2004-12-15 CN CN2004800375666A patent/CN1893944B/zh active Active
- 2004-12-15 US US10/596,509 patent/US7655642B2/en active Active
- 2004-12-15 NZ NZ547795A patent/NZ547795A/xx unknown
- 2004-12-15 WO PCT/EP2004/053497 patent/WO2005058318A1/en active Application Filing
- 2004-12-15 BR BRPI0417609A patent/BRPI0417609B8/pt active IP Right Grant
- 2004-12-15 SG SG200901893-8A patent/SG151288A1/en unknown
- 2004-12-15 DE DE602004023876T patent/DE602004023876D1/de active Active
- 2004-12-17 TW TW100107837A patent/TWI389890B/zh active
- 2004-12-17 AR ARP040104751A patent/AR047060A1/es active IP Right Grant
- 2004-12-17 TW TW093139380A patent/TWI374879B/zh active
-
2006
- 2006-06-15 IL IL176358A patent/IL176358A/en active IP Right Grant
- 2006-06-15 ZA ZA200604971A patent/ZA200604971B/xx unknown
- 2006-07-18 NO NO20063324A patent/NO337622B1/no unknown
-
2007
- 2007-03-19 HK HK07102919.7A patent/HK1095742A1/xx unknown
-
2009
- 2009-11-24 US US12/624,708 patent/US8778920B2/en active Active
-
2013
- 2013-03-12 US US13/796,377 patent/US9040511B2/en active Active
-
2014
- 2014-05-23 US US14/285,760 patent/US9365517B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL176358A0 (en) | 3-cyano-quinoline derivatives with antiproliferative activity | |
| PL377514A1 (pl) | Pochodne benzoazolilopiperazyny o działaniu antagonistycznym wobec VR1 | |
| IL174533A0 (en) | Quinazoline derivatives as antiproliferative agents | |
| AP1850A (en) | Spiroindolineplperidine derivatives | |
| EG24050A (en) | Heterocylocarboxamide derivatives | |
| HK1077068A1 (en) | Azolidinone-vinyl fused-benzene derivatives | |
| EP1522540A4 (de) | Azaarenderivate | |
| HK1088602A1 (en) | 2-pyridinecarboxamide derivatives | |
| HK1088326A1 (en) | Piperidine-benzenesulfonamide derivatives | |
| PL375588A1 (en) | Pyrimido compounds having antiproliferative activity | |
| HK1089443A1 (en) | Imidazol-4-yl-ethynyl-pyridine derivatives | |
| GB0317665D0 (en) | Qinazoline derivatives | |
| PL1682493T3 (pl) | Pochodne amidoacetonitrylu | |
| HK1086842A1 (en) | Macrolide-conjugates with anti-inflammatory activity | |
| IL175189A0 (en) | N-thiazol-2-yl-benzamide derivatives | |
| PL374529A1 (en) | N-biarylmethyl aminocycloalkanecarboxamide derivatives | |
| PT1706373E (pt) | Derivados de amidoacetonitrilo | |
| DE60326941D1 (en) | Rs | |
| HK1099649A1 (en) | Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives 5-- | |
| EP1531854A4 (de) | O-derivatisierte nocathiacin-derivate | |
| GB0319793D0 (en) | Pyridinylmorpholine derivatives | |
| HRP20040318A2 (en) | Furochromen derivative with anti-inflammaroty activity | |
| MY144310A (en) | 3-cyano-quinoline deriatives with antiproliferative activity | |
| AU2003225764A8 (en) | Aza-thioxanthenones with antitumor activity | |
| AU2003224677A8 (en) | Aza-benzothiopyranoindazoles with antitumor activity |